BSA and ABCB1 polymorphism affect the pharmacokinetics of sunitinib and its active metabolite in Asian mRCC patients receiving an attenuated sunitinib dosing regimen
Crossref DOI link: https://doi.org/10.1007/s00280-016-3104-9
Published Online: 2016-08-02
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chae, Jung-woo
Teo, Yi Ling
Ho, Han Kiat
Lee, Jaeyeon
Back, Hyun-moon
Yun, Hwi-yeol
Karlsson, Mats O.
Kwon, Kwang-il
Chan, Alexandre
License valid from 2016-08-02